Skip to main content

iSpecimen Inc.

ISPC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001558569

No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding iSpecimen Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ISPC: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders913+4
Shares916.3K1.16M+243.6K (+26.6%)
Value$5.35M$9.21M+$3.87M (+72.3%)

New holders (8)

Institutions that held iSpecimen Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ISPC in Q4 2021
InstitutionSharesValue% of portfolio
Empery Asset Management, LP466,333$3.64M7.60%
Vanguard Group Inc90,760$709.0K0.00%
Engineers Gate Manager LP26,959$211.0K0.01%
Geode Capital Management, LLC13,316$103.0K0.00%
Main Street Financial Solutions, LLC10,500$82.0K0.01%
Two Sigma Securities, LLC10,076$79.0K0.02%
Bank of America Corp2$00.00%
Morgan Stanley4$00.00%

Sold out (4)

Institutions that held iSpecimen Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ISPC in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Millennium Management LLC27,677$162.0K
Telemus Capital, LLC24,400$142.0K
Citadel Advisors LLC12,755$74.0K
Total Clarity Wealth Management, Inc.942$5.00K